Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/01/2003US20030083469 Allosteric control of nuclear hormone receptors
05/01/2003US20030083468 Polypeptide for use in the treatment of inflammation and liver disorders
05/01/2003US20030083467 Fusion proteins for use in the treatment of tumors and nervous sytem disorders
05/01/2003US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
05/01/2003US20030083465 Protein for use in treatment and prevention of angiogenesis
05/01/2003US20030083464 Novel peptides comprising repetitive units of amino acids and DNA sequences encoding the same
05/01/2003US20030083463 Novel proteins and nucleic acids encoding same
05/01/2003US20030083462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083461 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083339 Using antagonists of the Angiotensin II type 2 receptor (AT2 receptor) for example candesartan cilexetil; combination treatment with an ACE inhibitor (angiotensin converting enzyme=ACE); drug screening assays
05/01/2003US20030083304 CCAAT/enhancer binding protein-beta (C/EBPbeta) is a molecular target for cancer treatment
05/01/2003US20030083303 A replicated and packaged vector construct inside a virion particle in the helper cell, able expressing a foreign gene in a mammalian cell; use in transfection
05/01/2003US20030083298 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of DMS
05/01/2003US20030083291 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
05/01/2003US20030083290 Vector system
05/01/2003US20030083289 Herpesvirus vectors and their uses
05/01/2003US20030083287 ginS
05/01/2003US20030083265 TGF-beta inhibitors and methods
05/01/2003US20030083264 A peptide having the amino acid sequence proline, histidine, serine, arginine, and asparagine
05/01/2003US20030083262 Methods and compositions for treating inflammatory disorders
05/01/2003US20030083260 Cryptococcal mannoproteins or equivalents thereof for use in modulating neutrophil migration
05/01/2003US20030083258 Modulation of leukocyte-endothelial interactions following ischemia
05/01/2003US20030083257 Spliceable nucleotide sequence inserted into the wild-type factor viii cDNA at the original position of an intron of the genomic factor viii DNA; gene therapy; treatment of hemophilia
05/01/2003US20030083255 Peptide that inhibits stimulated endothelial cell proliferation
05/01/2003US20030083253 Polynucleotide encoding autoantigens associated with endometriosis
05/01/2003US20030083252 Neuronal uses of BMP-11
05/01/2003US20030083249 Increasing the level in the cells of a potassium channel modulatory protein
05/01/2003US20030083248 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083247 Amino acid sequences for endobiotic peptides; detecting freshness and treating stress
05/01/2003US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule
05/01/2003US20030083245 Novel receptors
05/01/2003US20030083243 Short bioactive peptides
05/01/2003US20030083242 Methods and compositions for treating or preventing peripheral neuropathies
05/01/2003US20030083237 Anti-angiogenic peptides for cancer treatment
05/01/2003US20030083235 Such as alpha-O-linked glycopeptides with clustered glycodomains which are useful as anticancer agents
05/01/2003US20030083229 Isolating T cells from mammal, incubating cells with protein expression product of activated oncogene or cancer-related gene associated with malignancy, detecting presence or absence of proliferation of T cells, determining malignancy
05/01/2003US20030082831 Apparatus for use in the synthesis of preferential biopolymers
05/01/2003US20030082815 Nucleotide sequences coding polypeptide for use in the biosynthesis of riboflavin
05/01/2003US20030082814 Secretion of T cell receptor fragments from recombinant escherichia coli cells
05/01/2003US20030082811 Preparing preferential viral vectors; provide packaging cell, transfect with nucleotide sequences coding viral vector, culture transfected cells, recover packaged vector
05/01/2003US20030082805 Methods for use of mpl ligands with primitive human stem cells
05/01/2003US20030082801 Nucleotide sequences coding membrane protein for use in the treatment of alzheimer's, pain and psychological disorders
05/01/2003US20030082799 Low-temperature inducible expression vector
05/01/2003US20030082790 Isolated enzymatic polypetide for use as tool in genetic engineering
05/01/2003US20030082788 Recombinant infectious laryngotracheitis virus and uses thereof
05/01/2003US20030082784 Novel peptide having osteogenetic activity and osteogenetic accelerator containing the same
05/01/2003US20030082781 Immunization of dairy cattle with GapC protein against Streptococcus infection
05/01/2003US20030082778 Regulation of promoter activity in cells
05/01/2003US20030082776 Nucleotide sequences coding enzymatic polypeptide for use in therapeutic drug design
05/01/2003US20030082770 Leukocyte adhesion inhibitor-1 polypeptide for use in the treatment of cancer
05/01/2003US20030082769 Human papillomavirus E2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor binding pocket
05/01/2003US20030082767 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082766 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082764 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082763 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082762 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082761 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082760 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082759 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082758 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors
05/01/2003US20030082757 Polypeptide for use in the treatment and prevention of diabetes, obesity, cancer, infections, metabolic, nervous system, immunological, blood disorders
05/01/2003US20030082753 Generation of expression vector for use as gene transfer tool; prepare nutrient broth, inoculate with yeast, propagate, transform yeast, express vector, recover encapsidated particle
05/01/2003US20030082749 Fc fusion proteins of human erythropoietin with increased biological activities
05/01/2003US20030082748 Nucleotide sequences coding polypeptides for use in the treatment of leukemia, tumors, psoriasis, chronic infections, autoimmune and fibrotic disorders; wound healing agents
05/01/2003US20030082747 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
05/01/2003US20030082744 Binding protein for use in as diagnostic tool in human therapeutics
05/01/2003US20030082743 Polypeptide sequences of human EDG-1c
05/01/2003US20030082742 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
05/01/2003US20030082741 Nucleotide sequences coding polypeptide for use as tool in genetic engineering
05/01/2003US20030082740 Antitumor agent for use in the treatment of cancer
05/01/2003US20030082739 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/01/2003US20030082738 Nucleotide sequences coding polypeptide for use in the treatment and prevention of pain and cardiovascular disorders
05/01/2003US20030082737 Nucleotide sequences coding polypeptide for use in the eating disorders
05/01/2003US20030082736 Nucleotide sequences coding polypeptide for use in the treatment of cachexia, sepsis, arthritis, diabetes, multiple sclerosis, fibrosis, cerebral, allograft and xenograft disorders
05/01/2003US20030082734 Mammalian receptor proteins; related reagents and methods
05/01/2003US20030082733 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082732 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082731 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082730 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082729 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082728 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082727 Modulatory proteins of human CNS receptors
05/01/2003US20030082726 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein
05/01/2003US20030082724 Nucleotide seqeuences for se as tool in plant genetic engineering
05/01/2003US20030082721 Transgenic animals expressing androgen receptor complex-associated protein
05/01/2003US20030082719 Generation of preferential lymphocyte receptor; generate nucleotide sequence coding receptor protein, transform cell, express nucleotide sequences, recover receptor protein, evaluate binding activity
05/01/2003US20030082718 52908, a human potassium channel, and uses thereof
05/01/2003US20030082717 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082716 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082715 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082714 Novel nucleic acid and polypeptide
05/01/2003US20030082712 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082711 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082710 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082709 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082708 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082707 Membrane protein for use as tool in human therapeutics and diagnostics
05/01/2003US20030082706 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
1 ... 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 ... 2916